Mechanism of Anti-α-Synuclein Immunotherapy
Journal of Movement Disorders
;
: 14-19, 2016.
Article
Dans Anglais
| WPRIM
| ID: wpr-187648
ABSTRACT
Immunization therapy targeting α-synuclein has emerged as a promising approach for Parkinson's disease and perhaps for other synucleinopathies. Several antibodies have shown therapeutic effects in mouse models of synucleinopathies and have alleviated the pathological and behavioral phenotypes of these mice. The mechanisms through which the immunization therapy works were initially puzzling, especially given that α-synuclein is a typical cytosolic protein. Recent studies, however, suggested that extracellular α-synuclein is an important pathogenic entity, and hence, a target for immunotherapy. Here, we review the literature describing immunization therapy for synucleinopathies in mouse models and provide current thoughts on the potential mechanisms underlying the therapeutic effects of α-synuclein immunotherapy.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Maladie de Parkinson
/
Phénotype
/
Immunisation
/
Cytosol
/
Utilisations thérapeutiques
/
Immunothérapie
/
Anticorps
Limites du sujet:
Animaux
langue:
Anglais
Texte intégral:
Journal of Movement Disorders
Année:
2016
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS